Smith & Nephew SNATS ROA 2006-2017 | SNN

Current and historical return on assets (ROA) values for Smith & Nephew SNATS (SNN) over the last 10 years.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.003B $4.765B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $118.585B 18.35
Abbott Laboratories (ABT) United States $108.312B 23.67
Stryker (SYK) United States $64.809B 25.92
Boston Scientific (BSX) United States $45.741B 25.50
Baxter (BAX) United States $39.631B 28.36
Zimmer Biomet Holdings (ZBH) United States $22.894B 14.42
ResMed (RMD) United States $15.554B 32.53
Perrigo (PRGO) Ireland $10.390B 14.57
Bio-Rad Laboratories (BIO) United States $8.957B 72.24
Hill-Rom Holdings (HRC) United States $6.056B 21.76
ICU Medical (ICUI) United States $6.049B 56.28
Canopy Growth (CGC) Canada $5.965B 0.00
Agios Pharmaceuticals (AGIO) United States $5.185B 0.00
Insulet (PODD) United States $5.051B 0.00
Haemonetics (HAE) United States $4.937B 50.84
Hutchison China MediTech (HCM) China $4.212B 0.00
Neogen (NEOG) United States $4.163B 71.90
GW Pharmaceuticals (GWPH) United Kingdom $4.110B 0.00
National Vision Holdings (EYE) United States $3.029B 0.00
NuVasive (NUVA) United States $2.707B 27.36
Quidel (QDEL) United States $2.607B 114.10
Phibro Animal Health (PAHC) United States $1.948B 28.92
Abaxis,Inc (ABAX) United States $1.905B 64.06
NxStage Medical (NXTM) United States $1.865B 0.00
VAREX IMAGING (VREX) United States $1.410B 21.73
Eagle Pharmaceuticals (EGRX) United States $1.184B 33.12
Cardiovascular Systems (CSII) United States $1.157B 0.00
Orthofix (OFIX) $1.081B 32.93
Owens & Minor (OMI) United States $1.073B 10.79
AtriCure (ATRC) United States $1.008B 0.00
OraSure Technologies (OSUR) United States $0.994B 60.28
TG Therapeutics (TGTX) United States $0.967B 0.00
Omeros (OMER) United States $0.966B 0.00
Cerus (CERS) United States $0.956B 0.00
MacroGenics (MGNX) United States $0.912B 0.00
Surmodics (SRDX) United States $0.773B 132.50
LeMaitre Vascular (LMAT) United States $0.702B 41.32
Meridian Bioscience (VIVO) United States $0.665B 23.43
PetIQ (PETQ) United States $0.637B 0.00
Evolus (EOLS) United States $0.594B 0.00
Insys Therapeutics (INSY) United States $0.555B 0.00
Lantheus Holdings (LNTH) United States $0.536B 14.00
Surface Oncology (SURF) United States $0.423B 0.00
NanoString Technologies (NSTG) United States $0.389B 0.00
Utah Medical Products (UTMD) United States $0.378B 25.02
Cytosorbents (CTSO) United States $0.365B 0.00
Quanterix (QTRX) United States $0.324B 0.00
BioLife Solutions (BLFS) United States $0.296B 0.00
Chimerix (CMRX) United States $0.226B 0.00
Rockwell Medical (RMTI) United States $0.218B 0.00
Fonar (FONR) United States $0.173B 10.52
Bovie Medical (BVX) United States $0.169B 0.00
Chembio Diagnostics (CEMI) United States $0.158B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.135B 0.00
Female Health (VERU) United States $0.112B 0.00
Trinity Biotech (TRIB) Ireland $0.106B 31.75
Oramed Pharmaceuticals (ORMP) Israel $0.099B 0.00
Neurotrope (NTRP) United States $0.090B 0.00
United-Guardian (UG) United States $0.090B 20.97
InfuSystems Holdings (INFU) United States $0.077B 0.00
CAS Medical Systems (CASM) United States $0.057B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.046B 0.00
Capricor Therapeutics (CAPR) United States $0.041B 0.00
Valeritas Holdings (VLRX) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Akers Biosciences Inc (AKER) United States $0.031B 0.00
Myomo (MYO) United States $0.028B 0.00
Senestech (SNES) United States $0.027B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
NeuroMetrix (NURO) United States $0.010B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.003B 0.00